Skip to main content
Toggle navigation
Search
Home
Back
Favorite
0
Like
Facebook
Print
Session V: Presentation of Selected Non-Colorectal Cancer Abstracts
O-4: Trifluridine/tipiracil (TAS-102) with or without bevacizumab in patients with pretreated metastatic esophagogastric adenocarcinoma (mEGA): A Danish randomized trial (LonGas)
Thursday, June 30, 2022
08:46 – 08:58
Location: Auditorium B; Level 0
Abstract Presenter(s)
Per Pfeiffer